Amarantus Bioscience Holdings Inc (AMBS)

[joboggi]

As I noted before, they do not have a principal investigator. It is almost October, the study can't start until the IRB meets and approves the study for each sight and they do not have a prinicipal yet.

They are looking at grants, that means they need money. It takes a long time to get grants, you just do not wave your hand and get a grant.

MJFF wants more data, iow, they are not going to fund this, because the data is coming from the IIb study, and no data will come before the IIb study.

If Lowe was phrasing the presentation, it would have been much more straightforward, as it is, you have to read between the lines, and also know how these things work.

I posted about this at the time, but you decided not to pay attention to it.

I did not say this, GC did in the ? period. Given GC's answers there is NO way that the ELtoprazine study can start this year.

This company is farcical, and seriously, any investor in biotech needs to know how things work before they pony up the dough.

ROFLOL